Delivery Order SPE2DB20D3303-SPE2DB25FZ8Z2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Vaxneuvance 0.5 mL syringes, a pneumococcal vaccine product. This non-set-aside, competitively awarded delivery order carries a ceiling value of $10,344.48 under a firm fixed-price arrangement, with an ultimate completion date of December 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $7,269.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on October 31, 2025, with an ultimate completion date of November 3, 2025. The contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $5,482.56 to AmerisourceBergen Drug Corp for VAXNEUVANCE 0.5 ML syringes on June 18, 2025, with a completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services under AmerisourceBergen's larger contract vehicle with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of VAXNEUVANCE 0.5 ML syringes valued at $20,438.65 with a firm fixed price contract type. This order is expected to be completed by July 21, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through a competitive process with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Vaxneuvance 0.5 ML syringes with a ceiling value of $6,715.65. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 26, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vaxneuvance 0.5 ML syringes, valued at $7,899.85. This firm fixed-price delivery order is scheduled for completion by July 22, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The award was competitively awarded without a set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,222.34 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes on a firm fixed-price basis. The award, issued on May 20, 2025, with an ultimate completion date of May 21, 2025, represents a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes valued at $1,370.34 on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price contract represents a non-competitive set-aside and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $7,758.36 delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on a firm fixed price basis. The contract, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a small-value transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. This award carries no set-aside designation, indicating it was competitively awarded through...
- The Defense Logistics Agency awarded a delivery order valued at $12,202.12 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vaxneuvance is a pneumococcal vaccine product, reflecting the ongoing federal...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FZ8Z2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VAXNEUVANCE 0.5 ML syringes valued at $5,552.15 on May 28, 2025, with an ultimate completion date of May 29, 2025. This competitive, firm fixed-price delivery order represents a non-set-aside award for pneumococcal vaccine supply to support federal medical procurement needs. The contract's place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply diverse pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The award reflects AmerisourceBergen's established capability as a major pharmaceutical distributor providing critical medical commodities including vaccines, brand-name and generic medications, and specialized medical supplies through competitive federal procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 5/28/25 |